Literature DB >> 21156227

Gene dosage effects in chronic lymphocytic leukemia.

Ludger Sellmann1, Rene Scholtysik, Markus Kreuz, Sandra Cyrull, Enrico Tiacci, Jens Stanelle, Alexander Carpinteiro, Holger Nückel, Tanja Boes, Stefan Gesk, Reiner Siebert, Ludger Klein-Hitpass, Ulrich Dührsen, Jan Dürig, Ralf Küppers.   

Abstract

To understand the influence of chromosomal alterations on gene expression in a genome-wide view, chromosomal imbalances detected by single nucleotide polymorphism (SNP) chips were compared with global gene expression in 16 cases of chronic lymphocytic leukemia (CLL). A strong concordance between chromosomal gain or loss and increased or reduced expression of genes in the affected regions was found, respectively. Regions of uniparental disomy (UPD) were rare and had usually no consistent influence on gene expression, but in one instance, a large UPD was associated with a downregulation of most genes in the affected chromosome. The frequently deleted miRNAs, MIRN15A and MIRN16-1, did not show a reduced expression in cases with monoallelic deletions. The BCL2 protein, considered to be downregulated by these miRNAs, was upregulated not only in CLL with biallelic deletion of MIRN15A and MIRN16-1, but also in cases with monoallelic deletion. This suggests a complex regulation of BCL2 levels in CLL cells. Taken together, in CLL, a global gene dosage effect exists for chromosomal gains and deletions and in some instances for UPDs. We did not confirm a consistent correlation between MIRN15A and MIRN16-1 expression levels and BCL2 protein levels, indicating a complex regulation of BCL2 expression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156227     DOI: 10.1016/j.cancergencyto.2010.09.002

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.

Authors:  Shaun Willimott; Simon D Wagner
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

2.  Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Authors:  G Cutrona; S Matis; M Colombo; C Massucco; G Baio; F Valdora; L Emionite; S Fabris; A G Recchia; M Gentile; C E Neumaier; D Reverberi; R Massara; S Boccardo; L Basso; S Salvi; F Rosa; M Cilli; S Zupo; M Truini; P Tassone; M Calabrese; M Negrini; A Neri; F Morabito; F Fais; M Ferrarini
Journal:  Leukemia       Date:  2017-01-05       Impact factor: 11.528

3.  Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.

Authors:  Maher Hanoun; Lewin Eisele; Masako Suzuki; John M Greally; Andreas Hüttmann; Semra Aydin; René Scholtysik; Ludger Klein-Hitpass; Ulrich Dührsen; Jan Dürig
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

4.  Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.

Authors:  Maria Göbel; Lewin Eisele; Michael Möllmann; Andreas Hüttmann; Patricia Johansson; René Scholtysik; Manuela Bergmann; Raymonde Busch; Hartmut Döhner; Michael Hallek; Till Seiler; Stephan Stilgenbauer; Ludger Klein-Hitpass; Ulrich Dührsen; Jan Dürig
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

5.  The shaping and functional consequences of the dosage effect landscape in multiple myeloma.

Authors:  Mehmet K Samur; Parantu K Shah; Xujun Wang; Stéphane Minvielle; Florence Magrangeas; Hervé Avet-Loiseau; Nikhil C Munshi; Cheng Li
Journal:  BMC Genomics       Date:  2013-10-02       Impact factor: 3.969

6.  Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).

Authors:  Beata Grygalewicz; Renata Woroniecka; Jolanta Rygier; Klaudia Borkowska; Iwona Rzepecka; Martyna Łukasik; Agnieszka Budziłowska; Grzegorz Rymkiewicz; Katarzyna Błachnio; Beata Nowakowska; Magdalena Bartnik; Monika Gos; Barbara Pieńkowska-Grela
Journal:  Mol Cytogenet       Date:  2016-01-06       Impact factor: 2.009

7.  Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1).

Authors:  Sunday S Oladipupo; Ashraf Ul Kabir; Craig Smith; Kyunghee Choi; David M Ornitz
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.